Get key Q3 2025 earnings call insights on Cytosorbents (CTSO): growth drivers, FDA progress, cost controls, and outlook.

By bne IntelliNews US-based supermajor Chevron unveiled its plans for the next five years at its investor day on November 12.

Universal Electronics Inc. (NASDAQ: UEIC) Q3 2025 Earnings Call Transcript November 6, 2025 Universal Electronics Inc. beats ...

Chevron projects 10%+ EPS growth, higher free cash flow, and strategic oil and gas expansion. The company targets 2–3% annual oil and gas production growth and $70 Brent breakeven.

BofA Securities maintains Buy on Chevron with $183 target, citing strong free cash flow, Hess synergies, structural cost ...

Chevron (NYSE: CVX) used its investor day in New York to signal a confident long-term outlook, unveiling a five-year plan ...

Here's a four-stock portfolio that could earn nearly $950 a year in cash. The post Investors: How to Turn $20K Into a Cash ...

Chevron announced on Wednesday its plans to increase oil and gas production and grow free cash flow annually by more than 10 percent through ...

In January 2026, several changes to Social Security will take effect, impacting everything from credits and taxes to benefit checks and full retirement age (FRA) rules. These changes don't only impact ...